Research suggests that GIP receptor activation contributes significantly to fat metabolism and energy expenditure in ways that GLP-1 alone does not address
With a pen, you dial a dose, press a button, and the device handles the rest
According to a study published in the New England Journal of Medicine, patients using Semaglutide achieved significant weight reduction compared to traditional methods
Athletes are not good candidates if: They are chronically under-fueling They have a history of an eating disorder or disordered eating If their nutrition, recovery, and other key lifestyle habits aren't yet well established Athletes may benefit, alongside comprehensive nutrition and medical care, if: They're experiencing overweight/obesity or metabolic disease Have significant inflammation or other medical conditions Have experienced certain peri/post-menopausal changes Even if you're a good candidate for GLP-1 meds, there are still potential risks
doi: 10.1038/s41598-017-00315-4 8
Taken together, our study uncovered that HU ameliorated diabetes-induced kidney damage by inhibiting inflammation and apoptosis